Côme De la Tour du Pin

Lysogene Announces the Conversion of the Reorganization Proceedings into Judicial Liquidation and its Delisting

Lysogene Announces the Conversion of the Reorganization Proceedings into Judicial Liquidation and its Delisting https://lysogene.com/wp-content/themes/crocal/images/empty/thumbnail.jpg 150 150 Lysogene Lysogene https://lysogene.com/wp-content/themes/crocal/images/empty/thumbnail.jpg May 26, 2023 May 26, 2023

Paris, France — 25 May 2023 at 06:00 pm CET — Lysogene (FR0013233475 – LYS), a…

Lysogene: Hearing scheduled on May 23, 2023 on the Possible Opening of Judicial Liquidation Proceedings

Lysogene: Hearing scheduled on May 23, 2023 on the Possible Opening of Judicial Liquidation Proceedings https://lysogene.com/wp-content/themes/crocal/images/empty/thumbnail.jpg 150 150 Lysogene Lysogene https://lysogene.com/wp-content/themes/crocal/images/empty/thumbnail.jpg May 15, 2023 May 15, 2023

Paris, France — 15 May 2023 at 06:00 pm CET — Lysogene (FR0013233475 – LYS), a…

Lysogene Announces Postponement of 2022 Financial Results Release

Lysogene Announces Postponement of 2022 Financial Results Release https://lysogene.com/wp-content/themes/crocal/images/empty/thumbnail.jpg 150 150 Lysogene Lysogene https://lysogene.com/wp-content/themes/crocal/images/empty/thumbnail.jpg April 29, 2023 April 29, 2023

Paris, France — 29 April 2023 at 06:00 pm CET — Lysogene (FR0013233475 – LYS), a…

Côme De la Tour du Pin

Lysogene Announces the Conversion of the Reorganization Proceedings into Judicial Liquidation and its Delisting

Lysogene: Hearing scheduled on May 23, 2023 on the Possible Opening of Judicial Liquidation Proceedings

Lysogene Announces Postponement of 2022 Financial Results Release

Lysogene COVID-19 update

Lysogene is developing therapies for children with CNS diseases.

Delivering Gene Therapy’s Promise

©2022 Lysogene. All rights reserved.

Get In Touch